Unidym spinning off medical nanotech company

03/19/2008 | CNNMoney

Nanotechnology developer Arrowhead Research Corp. said Tuesday its Unidym subsidiary plans to spin off Ensysce Biosciences, which will focus on medical uses for carbon nanotubes, including for drug delivery.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Counsel I – Clinical Contracts
Gilead Sciences
Foster City, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Vice President, Idaho Regional Director
Boise, ID